Bruker–Barclays: investor conference, 201903 supply service Bruker presents at Barclays Global Healthcare Conference

	Period	2019-03-14
	Partner, 1st	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Partner, 2nd	Barclays Capital Inc.
	Group	Barclays (Group)
	Product	Barclays Global Healthcare Conference 2019 Miami
	Product 2	analytical instrument
	Person	Laukien, Frank H. (Bruker 201204 President + CEO)
	Person 2	Minkova, Miroslava (Vertex 202303 Investor Relations formerly Bruker Corp 201611 Head of Investor Relations)

Bruker Corporation. (2/25/19). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA.

Bruker Corporation (Nasdaq: BRKR) announced today it will present at the following conferences:

8th Annual SVB Leerink Healthcare Conference, New York, NY
Thursday, February 28, 2019, at 10:30 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer

Cowen 39th Annual Health Care Conference, Boston, MA
Tuesday, March 12, 2019, at 10:40 a.m. Eastern Time
Gerald Herman, Chief Financial Officer

Barclays Global Healthcare Conference, Miami Beach, FL
Thursday, March 14, 2019, at 10:45 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer

Live audio webcasts of the presentations will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays will be posted on the Bruker Corporation Investor Relations website after each event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.

Contact :

Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
E: Miroslava.Minkova@Bruker.com